NextGen Biomed Ltd. — Delisting Announcement 2026

Jan 18, 2026

{0}------------------------------------------------

January 18, 2026 464440.docx

To: TASE Members

Dear Sir/Madam,

Re: NEXTGEN BIOMED LTD

• 1. On January 16, 2026 the Company announced that, in accordance with ISA's position, the Company is a "shell company".
• 1. According to the fourth part of TASE's rules, the definition of a company as a "shell company" is a cause for transferring its securities to the maintenance list. In light of the above, the company's shares (ISIN No. IL0010839301) will be transferred to the maintenance list on January 20, 2026, and the letter M will be added to the company's name and to the names of its shares.
• 1. The sector classification of the company will be changed from " HI-TECH BIOMED " sector, " MEDICAL EQUIPMENT " subsector, to "Investment & Holdings" sector, "Imactive+Shell" subsector on January 20, 2026
• 1. According to TASE's rules and regulations, shell company that wishes to renew trading in its securities on the main list has to fulfill the conditions required of a new company first listed on TASE. These terms apply to the company.
• 1. According to TASE's rules, a security shall be delisted from trade if 48 months have passed from the date on which the security ceased to be traded in the framework of the main list, and the conditions for the renewal of trade therein on the main list have not been fulfilled, without further discussion by the board of directors.

Sincerely

)-(

Listing companies compliance unit